The count applies to two capsules

Jarro-Dophilus EPS gives 10 billion CFU in a 131 mg proprietary blend per two-capsule serving. Its 60- and 120-capsule options therefore supply 30 and 60 labeled servings. A bottle containing 60 units is not automatically a 60-day supply. The page’s broader two- to four-month headline and capsule-based text should be reconciled with the current two-capsule directions before purchasing.

Eight useful strain identifiers

The panel names Lacticaseibacillus rhamnosus R0011, Lactobacillus helveticus R0052, Pediococcus acidilactici R1001, Lacticaseibacillus casei R0215, Bifidobacterium longum BB536, Lactiplantibacillus plantarum R1012, Bifidobacterium breve R0070, and Lactococcus lactis subsp. lactis R1058. This level of identity is more informative than an eight-species headline, although individual CFU amounts remain undisclosed within the total blend.

The blister pack and temperature limit

The official directions specify two capsules once daily with water or juice, preferably on an empty stomach. Jarrow says refrigeration is unnecessary, recommends a cool, dry location below 77°F, and says refrigeration extends shelf life. The live count is guaranteed within the Best Used Before date when storage conditions are followed. Keep those conditions with the purchase record instead of assuming shelf-stable means heat-proof.

Delivery and allergen details are separate

Enteroguard coating and individual blister packaging are presented as measures to protect organisms from stomach acid and environmental exposure. The panel nevertheless says the product contains trace milk and soy. A vegetarian or gluten-free label does not cancel that disclosure. The capsule’s potato starch and coating ingredients are also not quantified dietary fiber, so this should not be counted as a substantial fiber supplement.

A good comparison starts with the serving

EPS is useful beside one-capsule formulas when daily swallowing burden and coded strain disclosure matter. Its current $29.99 display needs a selected size and serving count before estimating daily spending. The brand’s clinical-strain language remains distinct from a trial of this exact blend during semaglutide or tirzepatide treatment, and no independent viability or outcome measurement is supplied by this review.

Official sources and evidence

Sources checked October 1, 2026. Brand pages document public offers and claims; agency references provide broader evidence and safety context.

  1. Jarro-Dophilus® EPS 10 Billion CFU Probiotic | Jarrow ↗Official product page · Checked 2026-10-01
  2. NCCIH: Probiotics — Usefulness and Safety ↗Probiotic evidence and safety · Checked 2026-10-01
  3. NIH ODS: Dietary Supplements — What You Need to Know ↗General evidence and safety · Checked 2026-10-01
  4. FDA: Questions and Answers on Dietary Supplements ↗Regulatory guidance · Checked 2026-10-01